Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Atlas FT-IR Spectrometer System

Product Description

atlas_ft_ir_system copy.gif

The Atlas FT-IR System is a high performance, automated laboratory reactor with an integrated mid-IR spectrometer. The combination of the Syrris Atlas and Bruker Optics Matrix-MF makes it ideal for real-time analysis of chemical reactions and processes.

The FT-IR Spectrometer is part of Atlas from Syrris, a revolutionary range of modular products, which can form a wide range of lab reactors - designed specifically for research and development chemists. Atlas offers manual or automated control of one or many reactions at a time with volumes from 5 litres to 1ml in jacketed reactors, flasks or vials.

Features & Benefits

Real time, in situ, quantitative analysis: Can be used for analysing product yield, impurities, reaction kinetics, mechanism, end point, etc.

Easy to upgrade: Calorimetry, pH control, gravimetric or volumetric reagent addition, crystallizations, parallel reactions, etc.

Wide temperature and pressure range: -80°C to +180°C and vacuum to 300bar† (†with custom reactors).

Fully automated with integrated analysis: Fully automated reactor control. IR data from the Matrix-MF can be displayed alongside other process data in the Atlas Software.

Wide range of vessel sizes: 50ml, 100ml, 250ml, 500ml, 1L, 2L, 3L* and 5L* (*with remote mount).

Quick change vessel: The oil drain unit, jacketed vessel clamp, auto aligning stirrer and quick oil connectors allow vessels to be changed in under a minute.

Wide wave number range: Analysis is possible from 3,500 to 560cm-1

Easy to use: Twist and click knob, large display and intuitive “drag and drop” software.

Robust: An extremely chemically resistant reactor system and FTIR probe with vibration resistant optics.

Compact: The Atlas footprint of 23cm (9”) square and Matrix-MF footprint of 30cm (12”) square easily fits into fume cupboards.

Product Atlas FT-IR Spectrometer System
Company Syrris Ltd - Product Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Syrris Ltd - Product Directory
Unit 1, Anglian Business Park Orchard Road, Royston Herts SG8 5TW United Kingdom

Tel: +44 (0) 1763 242555
Fax: +44 (0) 1763 242 992
Email: info@syrris.com



Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!